No Data
No Data
Personalis Full Year 2024 Earnings: Beats Expectations
Personalis' Earnings Call: Growth Amid Challenges
Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Milestone Pharmaceuticals (MIST) and Personalis (PSNL)
Lake Street Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $9
Personalis Is Maintained at Buy by Needham
A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts